Atopic Dermatitis
Latest News
Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis
Lebrikizumab remains under review in the United States.
Latest News
AAD updates guidelines for managing AD with phototherapy and systemic therapies
The work group recommended the inclusion of active comparator arms in randomized, controlled trials as new systemic therapies continue to be...
Latest News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
From the Journals
Dupilumab-associated lymphoid reactions require caution
In cases involving unexpected responses or atypical presentations, clinicians must have a low threshold for stopping dupilumab.
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
Latest News
Phase 3 trial supports topical JAK inhibitor for AD in young children
Already approved in adolescents and adults, topical ruxolitinib was found safe and effective in children.
From the Journals
Adolescents with atopic dermatitis more likely to have experienced bullying, study finds
“Clinicians, families, and schools should address and monitor bullying among adolescents.”
Latest News
Topical botanical drug coacillium curbs childhood alopecia
Coacillium cutaneous solution is also under investigation as a treatment for persistent chemotherapy-induced alopecia, atopic dermatitis, and...
Latest News
Patch testing finds higher prevalence of ACD among children with AD
AD and ACD both present with red, itchy, eczema-like patches and plaques and can be “really hard to differentiate.”
Latest News
FDA issues letter regarding lebrikizumab review for atopic dermatitis
The agency cited concerns related to an inspection of a third-party contract manufacturer.
Latest News
Study finds inflammatory bowel disease risk higher in children, adults with atopic dermatitis
AD has been associated with an increasing number of comorbidities, including IBD, but studies linking AD with IBD have had mixed results,...